Cefpodoxime
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cefpodoxime
Description:
Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2].Product Name Alternative:
Cefpodoxime acid; R 3763UNSPSC:
12352005Hazard Statement:
H317, H334Target:
Antibiotic; BacterialType:
Reference compoundRelated Pathways:
Anti-infectionApplications:
COVID-19-immunoregulationField of Research:
Infection; CancerAssay Protocol:
https://www.medchemexpress.com/cefpodoxime.htmlPurity:
99.48Solubility:
DMSO : 250 mg/mL (ultrasonic)Smiles:
O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)OMolecular Formula:
C15H17N5O6S2Molecular Weight:
427.46Precautions:
H317, H334References & Citations:
[1]Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19 (5) :377-9.|[2]Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33 (3) :495-508.|[3]Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13 (2) :118-25.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
LaunchedIsoform:
β-lactamCAS Number:
[80210-62-4]
